National Express Group PLC
Publication of Prospectus
The following Prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Prospectus dated 13 June 2022 (the "Prospectus") relating to the annual update of the £1,500,000,000 Euro Medium Term Note Programme of National Express Group PLC, guaranteed by West Midlands Travel Limited (the "Programme"). This RNS announcement does not relate to any issuance under the Programme.
To view the Prospectus, please paste the following URL into the address bar of your browser.
http://www.rns-pdf.londonstockexchange.com/rns/6822O_1-2022-6-13.pdf
A copy of the Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Enquiries to National Express:
| Chris Davies, Group Finance Director | 0121 460 8655 |
| Louise Richardson, Head of Investor Relations | 07827 807766 |
National Express Group PLC
National Express House
Birmingham Coach Station
Mill Lane
Digbeth B5 6DD
United Kingdom
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirement. The Prospectus does not constitute an offer of securities for sale in the United States. The securities described in the Prospectus have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended, or under any relevant securities laws of any state of the United States of America and may not be offered, sold or delivered in the United States of America or to, or for the account of or benefit of, U.S. Persons, subject to certain limited exemptions.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.